Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Current Assets (2016 - 2025)

Historic Current Assets for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to $416.8 million.

  • Exponent's Current Assets rose 101.92% to $416.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $416.8 million, marking a year-over-year increase of 101.92%. This contributed to the annual value of $446.9 million for FY2025, which is 1774.53% up from last year.
  • According to the latest figures from Q4 2025, Exponent's Current Assets is $416.8 million, which was up 101.92% from $425.7 million recorded in Q3 2025.
  • Exponent's Current Assets' 5-year high stood at $452.8 million during Q4 2021, with a 5-year trough of $318.3 million in Q1 2023.
  • For the 5-year period, Exponent's Current Assets averaged around $382.7 million, with its median value being $378.1 million (2022).
  • In the last 5 years, Exponent's Current Assets surged by 2705.35% in 2021 and then crashed by 2288.29% in 2022.
  • Quarter analysis of 5 years shows Exponent's Current Assets stood at $452.8 million in 2021, then fell by 22.88% to $349.2 million in 2022, then grew by 8.7% to $379.5 million in 2023, then grew by 8.71% to $412.6 million in 2024, then grew by 1.02% to $416.8 million in 2025.
  • Its Current Assets stands at $416.8 million for Q4 2025, versus $425.7 million for Q3 2025 and $432.8 million for Q2 2025.